RVNC
Revance Therapeutics, Inc.
Director Philip J. Vickers bought $98K of Revance Therapeutics, Inc.
Bought$98,393
$31.24Price
3,150Shares
+105%Stake
What RVNC did for a copier
Prices for RVNC after this filing aren't in yet.
Philip J. Vickers's record
1 other buy on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Mar 16. Filed Fri, Mar 16, 8:05 PM ET, after the close. Not investment advice.